TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33657282

Group type: EXPERIMENTAL
Intervention: Genetic markers and lifestyle factors for longevity classification
Number of subjects: 15651

Group type: COMPARATOR
Intervention: Genetic association with longevity loci
Number of subjects: 15651

Group type: COMPARATOR
Intervention: Polygenic risk scores and Mendelian randomization analyses
Number of subjects: 15651
Study: 35944602

Group type: EXPERIMENTAL
Intervention: Interdisciplinary pain management program (3-week duration)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Usual care (TAU)
Number of subjects: 103
Study: 34276288

Group type: EXPERIMENTAL
Intervention: Wearable cyborg Hybrid Assistive Limb (HAL)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional gait training (CGT)
Number of subjects: 40
Study: 32897297

Group type: EXPERIMENTAL
Intervention: Nortriptyline at burn-in
Number of subjects: 402

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 402
Study: 35981838

Group type: EXPERIMENTAL
Intervention: RenalGuard (PLC Medical Systems)
Number of subjects: 259

Group type: COMPARATOR
Intervention: Intravenous saline hydration (control)
Number of subjects: 259
Study: 33030846

Group type: EXPERIMENTAL
Intervention: Yoga (performed twice a week for ten sessions)
Number of subjects: 12
Study: 35546299

Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT) with 915 nm diode laser (1.5 W, duty cycle of 60%, energy density of 72 J cm²)
Number of subjects: 32
Study: 33437904

Group type: EXPERIMENTAL
Intervention: Machine learning algorithm using soluble immune markers (SIMs)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Machine learning algorithm using a combination of IL-2, MIG/CCL9, RANTES/CCL5, SCF, and TRAIL
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Hepatitis B core antigen
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Single SIMs at the time of NA stop
Number of subjects: 43
Study: 33549155

Group type: EXPERIMENTAL
Intervention: 3D navigation for sacroiliac screw fixation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional procedure for sacroiliac screw fixation
Number of subjects: 0

Group type: COMPARATOR
Intervention: 2D navigation for sacroiliac screw fixation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Navigation-assisted pedicle screw stabilization
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Joint replacements (various procedures)
Number of subjects: 0
Study: 34090838

Group type: EXPERIMENTAL
Intervention: PSE strategies implemented at 3 WIC clinics
Number of subjects: 246

Group type: COMPARATOR
Intervention: Control clinics
Number of subjects: 246
Study: 32985237

Group type: EXPERIMENTAL
Intervention: Nutritional supplementation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of nutritional supplementation and resistance exercise
Number of subjects: 0
Study: 34142184

Group type: EXPERIMENTAL
Intervention: 5 ml of autologous micro-fragmented adipose tissue
Number of subjects: 31
Study: 32319087

Group type: EXPERIMENTAL
Intervention: 0.15 mg/kg rocuronium iv
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 0.30 mg/kg rocuronium iv
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no additional drug administration)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: All groups (including control)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Rocuronium administration
Number of subjects: 40
Study: 36184206

Group type: EXPERIMENTAL
Intervention: Mediterranean Diet (MD)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Week on Week off (WOWO)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: 6‐Hour Time‐Restricted Eating (TRE‐6)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: 8‐Hour Time‐Restricted Eating (TRE‐8)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Alternative Day Diet (ADD)
Number of subjects: 360
Study: 33914302

Group type: EXPERIMENTAL
Intervention: Systemic lymphadenectomy (SLND) in 169 patients (70.1%)
Number of subjects: 241

Group type: COMPARATOR
Intervention: Control group (72 patients (29.9%) who did not undergo SLND)
Number of subjects: 241
Study: 35719707

Group type: EXPERIMENTAL
Intervention: Curcumin (500 mg twice a day)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Vitamin E (500 mg twice a day)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo (500 mg microcrystalline cellulose twice a day)
Number of subjects: 84
Study: 32687612

Group type: EXPERIMENTAL
Intervention: ANS-6637 (36 participants)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo (12 participants)
Number of subjects: 48
Study: 32619032

Group type: EXPERIMENTAL
Intervention: P3-MumBubVax intervention
Number of subjects: 0
Study: 32520623

Group type: EXPERIMENTAL
Intervention: KBP-5074 0.25 mg
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: KBP-5074 0.5 mg
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: KBP-5074 (both doses)
Number of subjects: 240
Study: 33653633

Group type: EXPERIMENTAL
Intervention: Biodegradable-Polymer Sirolimus-Eluting Stents (BP-SES)
Number of subjects: 1131

Group type: COMPARATOR
Intervention: Durable-Polymer Everolimus-Eluting Stents (DP-EES)
Number of subjects: 1131
Study: 34856759

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 65

Group type: COMPARATOR
Intervention: High-Intensity Interval Training (HIIT) with Whole-Body Cryotherapy (WBC)
Number of subjects: 65
Study: 35271932

Group type: EXPERIMENTAL
Intervention: hs‐cTnI testing
Number of subjects: 46927
Study: 35320960

Group type: EXPERIMENTAL
Intervention: Median approach for subarachnoid block
Number of subjects: 100

Group type: COMPARATOR
Intervention: Paramedian approach for subarachnoid block
Number of subjects: 100

Group type: COMPARATOR
Intervention: Both approaches (Median and Paramedian)
Number of subjects: 100
Study: 32677982

Group type: EXPERIMENTAL
Intervention: Toremifene (TOR)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Tamoxifen (TAM)
Number of subjects: 92
Study: 34197173

Group type: EXPERIMENTAL
Intervention: Broad belief induction task
Number of subjects: 0

Group type: COMPARATOR
Intervention: Narrow belief induction task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Film clip viewing
Number of subjects: 0
Study: 34131075

Group type: EXPERIMENTAL
Intervention: Active Facebook users
Number of subjects: 0

Group type: COMPARATOR
Intervention: Deactivated Facebook profiles
Number of subjects: 0
Study: 32197408

Group type: EXPERIMENTAL
Intervention: Healthy diet (HD)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: HD plus De Simone Formulation probiotic blend
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: HD plus AISA d-Limonene
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: HD plus Argan oil
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Anxiety
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: PCS-HRQoL
Number of subjects: 125
Study: 32343102

Group type: EXPERIMENTAL
Intervention: OCTA-guided PDT
Number of subjects: 45

Group type: COMPARATOR
Intervention: ICGA-guided PDT
Number of subjects: 45
Study: 35420044

Group type: EXPERIMENTAL
Intervention: Joint Attention, Symbolic Play, Engagement, and Regulation strategies embedded during small group activities
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard preschool curriculum
Number of subjects: 0
Study: 34242270

Group type: EXPERIMENTAL
Intervention: Learner-centered teleconference
Number of subjects: 38

Group type: COMPARATOR
Intervention: Traditional live-style conference
Number of subjects: 38
Study: 32022771

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 10010

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 10010

Group type: EXPERIMENTAL
Intervention: Aspirin in patients with previous percutaneous coronary intervention
Number of subjects: 10010

Group type: COMPARATOR
Intervention: Control (placebo for both aspirin and clonidine)
Number of subjects: 10010
Study: 35564755

Group type: EXPERIMENTAL
Intervention: Nurse-facilitated ACP conversations
Number of subjects: 22
Study: 32897367

Group type: EXPERIMENTAL
Intervention: Ceftobiprole
Number of subjects: 679

Group type: COMPARATOR
Intervention: Vancomycin plus Aztreonam
Number of subjects: 679
Study: 35020171

Group type: EXPERIMENTAL
Intervention: Adaptive metronome
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Traditional metronome
Number of subjects: 20
Study: 32306943

Group type: EXPERIMENTAL
Intervention: Healthy Start-Départ Santé (HSDS) intervention group
Number of subjects: 897

Group type: COMPARATOR
Intervention: Control group (usual practice)
Number of subjects: 897
Study: 35889834

Group type: EXPERIMENTAL
Intervention: Natural nitric oxide‐containing soybean lettuce extract
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 33335323

Group type: EXPERIMENTAL
Intervention: ChAdOx1 nCoV-19 (AZD1222) vaccine
Number of subjects: 0
Study: 32138630

Group type: EXPERIMENTAL
Intervention: Randomized Response Technique (RRT) (n = 754)
Number of subjects: 1246

Group type: COMPARATOR
Intervention: Direct Questioning (DQ) (n = 492)
Number of subjects: 1246
Study: 35081564

Group type: EXPERIMENTAL
Intervention: Combination pulsed-dye laser (PDL) and nonablative fractional laser (NAFL)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 76
Study: 34836240

Group type: EXPERIMENTAL
Intervention: L-carnitine tartrate at 50 µM and creatine monohydrate at 0.5 µM combined
Number of subjects: 0

Group type: COMPARATOR
Intervention: Creatine with LMP formulation at 51 mg/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: LMP formulated L-carnitine at 500 mg with LMP formulated creatine at 100, 200, or 500 mg
Number of subjects: 0
Study: 33291975

Group type: EXPERIMENTAL
Intervention: Meloxicam intravenous (30 mg once daily)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Meloxicam intravenous
Number of subjects: 0
Study: 33371107

Group type: EXPERIMENTAL
Intervention: Qiangji Jianli Capsule (QJC)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study: 33141228

Group type: EXPERIMENTAL
Intervention: Curved vertebroplasty needle (group C)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Straight vertebroplasty needle (group U)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Straight vertebroplasty needle (group B)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 96
Study: 32024411

Group type: EXPERIMENTAL
Intervention: WBV exercise
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control (Sham WBV)
Number of subjects: 42
Study: 35020038

Group type: EXPERIMENTAL
Intervention: Yigu®
Number of subjects: 458

Group type: COMPARATOR
Intervention: Aclasta®
Number of subjects: 458

Group type: EXPERIMENTAL
Intervention: Yigu® and Aclasta®
Number of subjects: 458
Study: 33691519

Group type: EXPERIMENTAL
Intervention: Parent ratings of child functioning before treatment
Number of subjects: 100

Group type: COMPARATOR
Intervention: Clinician ratings of child functioning
Number of subjects: 100
Study: 32332545

Group type: EXPERIMENTAL
Intervention: Computer‐aided design and manufacturing cutting and drilling guides with prebent titanium plates
Number of subjects: 46

Group type: COMPARATOR
Intervention: Computer‐aided design and manufacturing splints
Number of subjects: 46
Study: 36303331

Group type: COMPARATOR
Intervention: Adropin levels in Alzheimer's disease (AD) group
Number of subjects: 128

Group type: COMPARATOR
Intervention: MOTS‐c levels in acute ischemic stroke (AIS) and Alzheimer's disease (AD) groups
Number of subjects: 128

Group type: COMPARATOR
Intervention: MOTS‐c levels in multiple sclerosis (MS) group
Number of subjects: 128
Study: 33069883

Group type: EXPERIMENTAL
Intervention: Time-domain OCT (TD OCT)
Number of subjects: 516

Group type: EXPERIMENTAL
Intervention: Synthesized spectral-domain OCT (SD OCT)
Number of subjects: 516

Group type: EXPERIMENTAL
Intervention: Cox regression modeling for TD OCT
Number of subjects: 516

Group type: EXPERIMENTAL
Intervention: Cox regression modeling for synthesized SD OCT
Number of subjects: 516

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 516
Study: 32279367

Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 35088109

Group type: EXPERIMENTAL
Intervention: Group B (arms on a pillow)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Group A (arms repositioned)
Number of subjects: 400
Study: 34020837

Group type: EXPERIMENTAL
Intervention: Continuous positive pressure treatment for OSA
Number of subjects: 0

Group type: COMPARATOR
Intervention: Best treatment of each disease separately and recognition and treatment of comorbidities
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Obesity surgery when indicated
Number of subjects: 0
Study: 32057716

Group type: EXPERIMENTAL
Intervention: Intermittent fasting (IF) - 30% of energy needs on fast days
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Calorie restriction (CR) - 70% of energy needs daily
Number of subjects: 260

Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Intermittent fasting (IF)
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Calorie restriction (CR)
Number of subjects: 260
Study: 35130863

Group type: EXPERIMENTAL
Intervention: Group H (intraoperative warming set to 42 °C)
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Group LH (intraoperative warming set to 42 °C for the first hour then set to 38 °C)
Number of subjects: 218

Group type: COMPARATOR
Intervention: Group L (intraoperative warming set to 38 °C)
Number of subjects: 218

Group type: COMPARATOR
Intervention: Group L
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Group H
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Group LH
Number of subjects: 218
Study: 34684312

Group type: EXPERIMENTAL
Intervention: 6 g of L-citrulline
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 35176740

Group type: EXPERIMENTAL
Intervention: Cognitive Insight (CI)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Jumping to Conclusions (JTC)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Theory of Mind (ToM)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Cognitive variables
Number of subjects: 77
Study: 32408390

Group type: EXPERIMENTAL
Intervention: Tamsulosin (0.4 mg once a day)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Mirabegron (50 mg once a day)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 161
Study: 35655485

Group type: EXPERIMENTAL
Intervention: Percutaneous Kyphoplasty (PKP)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Percutaneous Vertebroplasty (PVP)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control (Conservative Treatment)
Number of subjects: 150
Study: 32935747

Group type: EXPERIMENTAL
Intervention: 1-sample FIT (FIT 1)
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: 2-sample FIT (FIT 2)
Number of subjects: 289
Study: 36250332

Group type: EXPERIMENTAL
Intervention: Parental stroking preprocedure
Number of subjects: 112

Group type: COMPARATOR
Intervention: Parental stroking postprocedure
Number of subjects: 112
Study: 33040092

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 35799169

Group type: EXPERIMENTAL
Intervention: Rubus idaeus leaf extract 400 mg
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Rubus idaeus leaf extract 200 mg
Number of subjects: 198

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 198
Study: 34002611

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 30
Study: 36206494

Group type: EXPERIMENTAL
Intervention: Orthodontic treatment with fixed appliances
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Previous dental trauma
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Endodontically treated teeth
Number of subjects: 0
Study: 34133348

Group type: EXPERIMENTAL
Intervention: Edaravone (EDA) administered intravenously 30 min before surgery
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Edaravone (EDA)
Number of subjects: 160
Study: 32916151

Group type: EXPERIMENTAL
Intervention: Fructose (25% of energy requirements)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: High Fructose Corn Syrup (HFCS) (25% of energy requirements)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Glucose (25% of energy requirements)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Fructose and Glucose interaction (post hoc analysis)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Aspartame (control)
Number of subjects: 145
Study: 37270883

Group type: EXPERIMENTAL
Intervention: Intracoronary tirofiban (25 mcg/kg infused over 5 minutes followed by 0.15 mcg/kg/min for 12-18 hours)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Intracoronary tirofiban
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (direct PCI during index procedure)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study: 35675613

Group type: EXPERIMENTAL
Intervention: Mifepristone pretreatment followed by misoprostol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Misoprostol alone
Number of subjects: 0
Study: 32556821

Group type: EXPERIMENTAL
Intervention: Franseen-tip needle
Number of subjects: 22

Group type: COMPARATOR
Intervention: Fork-tip needle
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Both needles
Number of subjects: 22
Study: 34029019

Group type: EXPERIMENTAL
Intervention: Teachers' knowledge of dental trauma (DT) management
Number of subjects: 1634

Group type: EXPERIMENTAL
Intervention: Teachers' training in dental trauma (DT) management
Number of subjects: 1634

Group type: EXPERIMENTAL
Intervention: Experience with dental trauma (DT) cases
Number of subjects: 1634

Group type: EXPERIMENTAL
Intervention: Knowledge about tooth avulsion management
Number of subjects: 1634
Study: 33170818

Group type: EXPERIMENTAL
Intervention: PrEP for women meeting CDC indicators regarding partner characteristics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PrEP for women with a recently incarcerated male partner
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PrEP for women with a recently released male partner
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Couples-based PrEP at time of release
Number of subjects: 0

Group type: COMPARATOR
Intervention: CDC-guideline scenarios
Number of subjects: 0
Study: 32314038

Group type: EXPERIMENTAL
Intervention: Obinutuzumab-chemotherapy
Number of subjects: 1202

Group type: COMPARATOR
Intervention: Rituximab-chemotherapy
Number of subjects: 1202
Study: 33484095

Group type: EXPERIMENTAL
Intervention: Boost articulation therapy (BArT)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Intensive minimal pair training (Control)
Number of subjects: 17
Study: 33039958

Group type: EXPERIMENTAL
Intervention: Combined immunotherapy (anti-PD-1 antibody) and antiangiogenic therapy
Number of subjects: 57
Study: 37851328

Group type: EXPERIMENTAL
Intervention: Restricted maintenance fluid strategy (40%)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual/liberal maintenance fluid strategy (70-80%)
Number of subjects: 100
Study: 33559895

Group type: EXPERIMENTAL
Intervention: Vitamin E levels in females
Number of subjects: 356

Group type: EXPERIMENTAL
Intervention: Reference Interval for Vitamin A
Number of subjects: 356

Group type: EXPERIMENTAL
Intervention: Reference Interval for Vitamin E (Total)
Number of subjects: 356

Group type: EXPERIMENTAL
Intervention: Reference Interval for Vitamin E (Females)
Number of subjects: 356

Group type: EXPERIMENTAL
Intervention: Reference Interval for Vitamin E (Males)
Number of subjects: 356

Group type: EXPERIMENTAL
Intervention: Vitamin A levels
Number of subjects: 356

Group type: EXPERIMENTAL
Intervention: Vitamin E levels
Number of subjects: 356
Study: 32125302

Group type: EXPERIMENTAL
Intervention: Frankel‐2 activator
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 51
Study: 33390481

Group type: EXPERIMENTAL
Intervention: Trastuzumab deruxtecan (T-DXd, ENHERTU®)
Number of subjects: 0
Study: 32404342

Group type: EXPERIMENTAL
Intervention: Canakinumab (4 mg/kg, maximum 300 mg subcutaneous every 4 weeks)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Canakinumab
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 36395695

Group type: EXPERIMENTAL
Intervention: 0.45 mg/day oral conjugated equine estrogens (o-CEE)
Number of subjects: 362

Group type: EXPERIMENTAL
Intervention: 50 μg/day transdermal 17β (tE2)
Number of subjects: 362

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 362
Study: 33419674

Group type: EXPERIMENTAL
Intervention: Herbal medicine therapy (Jinhaoartemisia antipyretic granules and Huoxiangzhengqi oral liquids)
Number of subjects: 22065

Group type: COMPARATOR
Intervention: Reference manual only
Number of subjects: 22065
Study: 36475244

Group type: EXPERIMENTAL
Intervention: 3 mg melatonin
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 5 mg melatonin
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 10 mg melatonin
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 33279531

Group type: EXPERIMENTAL
Intervention: Diabetes self-management education (DSME) sessions
Number of subjects: 291

Group type: COMPARATOR
Intervention: Control group (no DSME)
Number of subjects: 291
Study: 34168271

Group type: EXPERIMENTAL
Intervention: Maternal breast milk (MBM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Banked donor breast milk (BBM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High nutrient intervention diet (preterm formula - PTF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard diet (term formula - TF)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neonatal infection/NEC
Number of subjects: 0
Study: 34402024

Group type: EXPERIMENTAL
Intervention: Trans-resveratrol (500 mg orally once daily for 52 weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 33407753

Group type: EXPERIMENTAL
Intervention: Rehabilitation training (four different timelines for four phases of rehabilitation exercises)
Number of subjects: 200
Study: 32747036

Group type: EXPERIMENTAL
Intervention: Low-dose estradiol (0.5 mg) / dydrogesterone (2.5 mg)
Number of subjects: 0
Study: 35377882

Group type: EXPERIMENTAL
Intervention: E-SEE Steps (Incredible Years® Baby Book, targeted Infant/Toddler program if eligible)
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: E-SEE Steps
Number of subjects: 341

Group type: COMPARATOR
Intervention: Control (usual services)
Number of subjects: 341